Demant Net Income 2012-2023 | WILYY
- Demant net income for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
- Demant net income for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
- Demant annual net income for 2023 was $0.261B, a 11.59% decline from 2022.
- Demant annual net income for 2022 was $0.295B, a 26.26% decline from 2021.
- Demant annual net income for 2021 was $0.4B, a 132.81% increase from 2020.
Demant Annual Net Income (Millions of US $) |
|
---|---|
2023 | $261 |
2022 | $295 |
2021 | $400 |
2020 | $172 |
2019 | $219 |
2018 | $289 |
2017 | $266 |
2016 | $217 |
2015 | $214 |
2014 | $236 |
2013 | $233 |
2012 | $199 |
2011 | $224 |
Demant Quarterly Net Income (Millions of US $) |
|
---|---|
2023-12-31 | |
2023-06-30 | |
2022-12-31 | |
2022-06-30 | |
2021-12-31 | |
2021-06-30 | |
2020-12-31 | |
2020-06-30 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | |
2018-06-30 | |
2017-12-31 | |
2017-06-30 | |
2016-12-31 | |
2016-06-30 | |
2015-12-31 | |
2014-06-30 | |
2013-12-31 | |
2013-06-30 | |
2012-12-31 | |
2012-06-30 | |
2011-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $8.667B | $3.257B |
Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company's business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $195.617B | 25.27 |
Stryker (SYK) | United States | $137.290B | 32.08 |
Boston Scientific (BSX) | United States | $122.743B | 37.38 |
Medtronic (MDT) | Ireland | $114.552B | 17.05 |
EssilorLuxottica (ESLOY) | France | $108.842B | 0.00 |
Haleon (HLN) | United Kingdom | $48.651B | 35.57 |
Lonza Group Ag (LZAGY) | Switzerland | $46.030B | 0.00 |
ResMed (RMD) | United States | $35.117B | 30.92 |
Koninklijke Philips (PHG) | Netherlands | $30.774B | 23.39 |
Terumo (TRUMY) | Japan | $28.517B | 40.27 |
Zimmer Biomet Holdings (ZBH) | United States | $22.039B | 13.87 |
Baxter (BAX) | United States | $19.851B | 13.46 |
Insulet (PODD) | United States | $16.269B | 68.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.605B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.247B | 30.63 |
BellRing Brands (BRBR) | United States | $7.898B | 33.39 |
Lantheus Holdings (LNTH) | United States | $7.454B | 17.89 |
ICU Medical (ICUI) | United States | $4.261B | 40.67 |
Haemonetics (HAE) | United States | $4.084B | 20.20 |
TG Therapeutics (TGTX) | United States | $3.689B | 39.07 |
Neogen (NEOG) | United States | $3.599B | 37.75 |
Prestige Consumer Healthcare (PBH) | United States | $3.534B | 17.61 |
GN Store Nord (GNNDY) | Denmark | $3.509B | 21.14 |
Perrigo (PRGO) | Ireland | $3.499B | 11.06 |
Envista Holdings (NVST) | United States | $3.398B | 18.13 |
QuidelOrtho (QDEL) | United States | $3.063B | 19.30 |
Agios Pharmaceuticals (AGIO) | United States | $2.595B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.226B | 37.36 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.124B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $2.061B | 54.92 |
Warby Parker (WRBY) | United States | $1.614B | 0.00 |
AdaptHealth (AHCO) | United States | $1.497B | 10.81 |
InMode (INMD) | Israel | $1.464B | 9.32 |
AtriCure (ATRC) | United States | $1.372B | 0.00 |
Owens & Minor (OMI) | United States | $1.247B | 9.63 |
Verano Holdings (VRNOF) | United States | $1.184B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.123B | 0.00 |
Evolus (EOLS) | United States | $1.006B | 0.00 |
PetIQ (PETQ) | United States | $0.919B | 23.30 |
Phibro Animal Health (PAHC) | United States | $0.894B | 18.55 |
National Vision Holdings (EYE) | United States | $0.867B | 27.55 |
Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
Surmodics (SRDX) | United States | $0.549B | 116.64 |
Quanterix (QTRX) | United States | $0.489B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.488B | 14.72 |
Jin Medical (ZJYL) | China | $0.439B | 0.00 |
ZimVie (ZIMV) | United States | $0.435B | 40.41 |
Valneva SE (VALN) | France | $0.432B | 0.00 |
Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.389B | 0.00 |
Cerus (CERS) | United States | $0.324B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.324B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.320B | 8.25 |
Aurora Cannabis (ACB) | Canada | $0.319B | 0.00 |
Biote (BTMD) | United States | $0.307B | 14.18 |
Viemed Healthcare (VMD) | United States | $0.283B | 30.38 |
Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
Zynex (ZYXI) | United States | $0.257B | 45.00 |
Utah Medical Products (UTMD) | United States | $0.232B | 15.41 |
Omeros (OMER) | United States | $0.227B | 0.00 |
MacroGenics (MGNX) | United States | $0.200B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.194B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 67.33 |
FitLife Brands (FTLF) | United States | $0.153B | 20.64 |
Brainsway (BWAY) | Israel | $0.135B | 161.40 |
TriSalus Life Sciences (TLSI) | United States | $0.130B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.121B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.114B | 0.00 |
Veru (VERU) | United States | $0.113B | 0.00 |
Fonar (FONR) | United States | $0.111B | 11.44 |
Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
InterCure (INCR) | Israel | $0.087B | 14.62 |
Zevia PBC (ZVIA) | United States | $0.083B | 0.00 |
Cytosorbents (CTSO) | United States | $0.082B | 0.00 |
Modular Medical (MODD) | United States | $0.074B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.071B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Exagen (XGN) | United States | $0.055B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.051B | 3.35 |
Apyx Medical (APYX) | United States | $0.042B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
Agape ATP (ATPC) | $0.007B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 21.30 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |